Ganodermes

Ganoderma

Ganoderma, traditionally not associated with specific medicinal uses, is a fungal species that has been the subject of scientific research. Studies have shown that hypoxia can enhance the synthesis of ganoderic acid and inhibit biofilm development in Ganoderma lucidum, while also revealing the presence of two polysaccharides with antioxidant and immune-regulating properties. Additionally, findings indicate that FBG treatment may reduce lipid deposition and ROS levels, increase HDL-C, and boost antioxidant enzyme activities in liver cells. The scientific evidence is limited but suggests potential benefits for liver health and immune modulation. No significant safety concerns or drug interactions have been recorded to date.

En bref
Meilleure preuve
D
Précautions

Information uniquement. L'usage traditionnel ne signifie pas une efficacité prouvée. Les preuves et la sécurité varient — consultez les sources citées.

Ce que dit la science

  • L'hypoxie réduit les niveaux d'cAMP, augmentant la synthèse d'acide ganodéridique tout en inhibant le développement de pellicules biologiques chez Ganoderma lucidum. D PMID
  • Two polysaccharides from Ganoderma lucidum cultivated under forest conditions were isolated and found to have antioxidant and immune-regulating properties. D PMID
  • L'étude a éclairci le mécanisme d'encrassement des membranes par les glicopépides de Ganoderma lucidum lors de la nanofiltration et a optimisé les paramètres ultrasoniques assistés pour améliorer l'efficacité de séparation. D PMID
  • Le traitement par FBG a réduit l'accumulation de lipides et les niveaux de ROS tout en augmentant les activités d'enzymes antioxydantes et le HDL-C dans les cellules hépatiques. D PMID
  • L'intervention GLT a significativement atténué les symptômes de la colite et modulé le microbiote intestinale et les profils métaboliques chez les souris induites par DSS. D PMID
  • Les différences structurales des polysaccharides de Ganoderma lucidum (GLP) ont conduit à une modulation distincte du microbiote intestinal par rapport à d'autres polysaccharides testés. D PMID
  • The study developed an enzyme-assisted extraction method that increased the yield of Ganoderma lucidum polysaccharides by 6.96 times and showed immunomodulatory activity. D PMID
  • La disruption du sporoderm des spores de Ganoderma lucidum a augmenté le rendement de l'extraction et modifié les caractéristiques des polysaccharides, renforçant leur activité protectrice mitochondriale sans modifier la structure squelettique. D PMID

Frequently asked questions

What is Ganodermes?

Ganodermes (Ganoderma) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.

What does the scientific evidence say about Ganodermes?

8 sourced findings are recorded for Ganodermes; the strongest carries evidence grade D. For example: L'hypoxie réduit les niveaux d'cAMP, augmentant la synthèse d'acide ganodéridique tout en inhibant le développement de pellicules biologiques chez Ganoderma lucidum.

How strong is the evidence for Ganodermes?

The strongest finding for Ganodermes carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).

Is Ganodermes safe? What are the side effects?

No major safety issues are recorded for Ganodermes in our sources, but the data may be incomplete. Consult a qualified professional before use.

Does Ganodermes interact with medications?

No drug interactions are recorded for Ganodermes in our sources. This does not rule them out — check with a pharmacist.

What are the common names of Ganodermes?

Ganodermes is also known as: Ганодерма.

Is Ganodermes a proven treatment?

No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.

Sources

  1. T2 The Potential Alleviating Property Against NAFLD by Ganoderma lucidum With Bacteria-Enzyme Synergistic Fermentation. literature abstract metadata
  2. T2 Nanofiltration concentration process of Ganoderma lucidum glycopeptides and membrane fouling mechanism based on the ultrasonic-regulated adsorption and concentration kinetics. literature abstract metadata
  3. T2 Structural characterization and biological activity of polysaccharides from Ganoderma lucidum cultivated under forest conditions. literature abstract metadata
  4. T2 Hypoxia-induced downregulation of cAMP drives Ganoderic acid biosynthesis and restricts biofilm development in Ganoderma lucidum. literature abstract metadata
  5. T2 Sporoderm Disruption Reshapes the Chemical Characteristics and Enhances the Mitochondrial Protective Activity of Ganoderma lucidum Spore Polysaccharides via SIRT1/AMPK Signaling. literature abstract metadata
  6. T2 Comparative Insights into Digestion and Gut Microbiota Modulation of Polysaccharides from Ginseng, Ganoderma lucidum, and Dendrobium officinale. literature abstract metadata
  7. T2 Integrated Microbiome and Metabolomics Analysis Reveals That Ganoderma lucidum Triterpenoids Ameliorate Colitis Associated with the Modulation of the Gut Microbiota and Metabolic Profiles. literature abstract metadata
  8. T2 Enzyme-Assisted Extraction of Polysaccharides from Steam-Exploded Ganoderma lucidum and Its Yield, Structural Characterisation, and Immunomodulatory Activity. literature abstract metadata